Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenoma, Islet Cell × Bortezomib × 1 year × Clear all

Sponsor

Conditions

Multiple Myeloma 89 Neoplasms, Plasma Cell 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Leukemia, Myeloid, Acute 6 Immunoglobulin Light-chain Amyloidosis 6 Recurrence 5 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Paraproteinemias 3 Neoplasms 3 Lymphoma, Mantle-Cell 3 Lymphoma 3 Renal Insufficiency 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoproliferative Disorders 2 Leukemia 2 Burkitt Lymphoma 2 Breast Neoplasms 2 Amyloidosis 2 beta-Thalassemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thalassemia 1 Sarcoma, Myeloid 1 Plasmacytoma 1 Peripheral Nervous System Diseases 1 Neoplasm, Residual 1

Interventions

lutetium Lu 177 dotatate 3 Temozolomide 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 Capecitabine 3 Sunitinib 2 Octreotide 2 Everolimus 2 sargramostim 1 sapanisertib 1 montanide ISA 51 1 lanreotide 1 incomplete Freund's adjuvant 1 fludarabine phosphate 1 cabozantinib 1 belzutifan 1 atezolizumab 1 aflibercept 1 abemaciclib 1 X-Rays 1 Salts 1 Radiofrequency Ablation 1 Phantoms, Imaging 1 PM 01183 1 LY2940680 1 Interleukin-13 1 Injections 1 Immunoglobulin G 1 Fulvestrant 1 Fluorodeoxyglucose F18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡